亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

南京肽業(yè)生物科技有限公司多肽  

多肽,氨基酸

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > β-淀粉樣蛋白(1 - 42) | 107761-42-2
β-淀粉樣蛋白(1 - 42) | 107761-42-2
單價(jià) 面議對(duì)比
詢價(jià) 暫無
發(fā)貨 江蘇付款后3天內(nèi)
品牌 南京肽業(yè)
過期 長期有效
更新 2020-09-21 14:34
 
詳細(xì)信息

中文名稱:

beta-淀粉樣多肽-42

中文同義詞:

Β淀粉樣肽-42 (C端多肽);BETA-淀粉樣蛋白-42;BETA-淀粉樣多肽-42;Β-淀粉樣蛋白(1 - 42),;Β-AMYLOID PEPTIDE (1-42), RAT;Β-淀粉樣多肽(1-42);Β-淀粉樣多肽 1-42 95%;Β-淀粉樣多肽 AMYLOID Β PROTEIN FRAGMENT 1-42

英文名稱:

beta-Amyloid (1-42) human

英文同義詞:

BETA-AMYLOID PEPTIDE (1-42), HUMAN;DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA;AMYLOID BETA-PEPTIDE (1-42) (HUMAN);AMYLOID B-PROTEIN FRAGMENT 1-42;Amyloidb-Peptide(1-42)(human);H-Asp-Ala-Glu-Phe-Arg-His-Asp--Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-OH;H-asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Gly-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Ile-Ala-OH;Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala

CAS號(hào):

107761-42-2

分子式:

C203H311N55O60S1

分子量:

4514.04


©2025 南京肽業(yè)生物科技有限公司多肽 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:5141  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |